Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: A pilot randomised controlled trial (PD COMM pilot)

被引：29

作者：

Sackley C.M. ^{[1
]}

Smith C.H. ^{[2
]}

Rick C.E. ^{[3
]}

Brady M.C. ^{[4
]}

Ives N. ^{[3
,23
]}

Patel S. ^{[3
,23
]}

Woolley R. ^{[3
,23
]}

Dowling F. ^{[3
,23
]}

Patel R. ^{[5
]}

Roberts H. ^{[6
]}

Jowett S. ^{[7
,24
]}

Wheatley K. ^{[8
,23
]}

Kelly D. ^{[9
]}

Sands G. ^{[11
]}

Clarke C.E. ^{[7
,10
]}

Molloy S. ^{[12
]}

Pavel C. ^{[12
]}

Rowbottom C. ^{[12
]}

Tweedie E. ^{[12
]}

Clarke P.C. ^{[13
]}

Nicholl D. ^{[13
]}

Siddiqui F. ^{[13
]}

Kanakaratna C. ^{[13
]}

Bennett R. ^{[13
]}

Blachford K. ^{[13
]}

Boughey A. ^{[13
]}

Harrison T. ^{[13
]}

Basso M.N. ^{[13
]}

Pooler J. ^{[13
]}

Round J. ^{[13
]}

Smith A. ^{[13
]}

Waszkiewicz C. ^{[13
]}

Raw J. ^{[14
]}

Vassallo J. ^{[14
]}

Ansari A. ^{[14
]}

Birtwell K. ^{[14
]}

Brooke J. ^{[14
]}

Finnigan K. ^{[14
]}

Gillan N. ^{[14
]}

Johnson E. ^{[14
]}

Jowitt H. ^{[14
]}

Kennedy A. ^{[14
]}

Buccoliero R. ^{[15
]}

Isles C. ^{[15
]}

Meredith S. ^{[15
]}

Stemp C. ^{[15
]}

Ware L. ^{[15
]}

Cooper S. ^{[16
]}

Appleton S. ^{[16
]}

Durman H. ^{[16
]}

机构：

[1] King's College London, Faculty of Life Sciences and Medicine, London

[2] University College London, Division of Psychology and Language Science, Faculty of Brain Sciences, London

[3] University of Birmingham, Birmingham Clinical Trials Unit (BCTU), Birmingham

[4] Glasgow Caledonian University, Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow

[5] Parkinson's UK West Midlands Regional Branch, London

[6] University of Southampton, Faculty of Medicine, London

[7] University of Birmingham, Institute for Applied Health Research, Birmingham

[8] University of Birmingham, Cancer Research UK Clinical Trials Unit (CRCTU), Birmingham

[9] University of East Anglia, School of Rehabilitation Sciences, Norwich

[10] Sandwell and West Birmingham Hospitals NHS Trust, Department of Neurology, Clinical Neurology City Hospital, Dudley Road, Birmingham

[11] School of Health Sciences, University of Nottingham, Nottingham

来源：

Pilot and Feasibility Studies | / 4卷 / 1期

关键词：

Parkinson's disease; Pilot randomised controlled trial; Speech and language therapy;

D O I：

10.1186/s40814-017-0222-z

中图分类号：

学科分类号：

摘要：

Background: Speech-related problems are common in Parkinson's disease (PD), but there is little evidence for the effectiveness of standard speech and language therapy (SLT) or Lee Silverman Voice Treatment (LSVT LOUD®). Methods: The PD COMM pilot was a three-arm, assessor-blinded, randomised controlled trial (RCT) of LSVT LOUD®, SLT and no intervention (1:1:1 ratio) to assess the feasibility and to inform the design of a full-scale RCT. Non-demented patients with idiopathic PD and speech problems and no SLT for speech problems in the past 2 years were eligible. LSVT LOUD® is a standardised regime (16 sessions over 4 weeks). SLT comprised individualised content per local practice (typically weekly sessions for 6-8 weeks). Outcomes included recruitment and retention, treatment adherence, and data completeness. Outcome data collected at baseline, 3, 6, and 12 months included patient-reported voice and quality of life measures, resource use, and assessor-rated speech recordings. Results: Eighty-nine patients were randomised with 90% in the therapy groups and 100% in the control group completing the trial. The response rate for Voice Handicap Index (VHI) in each arm was ≥ 90% at all time-points. VHI was highly correlated with the other speech-related outcome measures. There was a trend to improvement in VHI with LSVT LOUD® (difference at 3 months compared with control: - 12.5 points; 95% CI - 26.2, 1.2) and SLT (difference at 3 months compared with control: - 9.8 points; 95% CI - 23.2, 3.7) which needs to be confirmed in an adequately powered trial. Conclusion: Randomisation to a three-arm trial of speech therapy including a no intervention control is feasible and acceptable. Compliance with both interventions was good. VHI and other patient-reported outcomes were relevant measures and provided data to inform the sample size for a substantive trial. © 2018 The Author(s).

引用

共 50 条

[1] PD COMM pilot: A pilot randomised controlled trial of Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease
Dowling, F.
Clarke, C. E.
Patel, S.
Woolley, R.
Ives, N. J.
Rick, C. E.
Wheatley, K.
Smith, C.
Brady, M.
Sackley, C. M.
MOVEMENT DISORDERS, 2014, 29 : S234 - S235
[2] PD COMM Pilot: A pilot randomised controlled trial of Lee Silverman voice treatment (LSVT) versus NHS speech and language therapy versus no intervention in Parkinson's
Sackley, C. M.
Patel, S.
Woolley, R.
Ives, N. J.
Rick, C. E.
Dowling, F.
Wheatley, K.
Smith, C.
Brady, M.
Clarke, C. E.
MOVEMENT DISORDERS, 2016, 31 : S619 - S619
[3] Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease: the PD COMM randomised controlled trial.
Sackley, C.
Rick, C.
Patel, S.
Woolley, R.
Brady, M.
Nicoll, A.
Dickson, S.
Beaton, G.
Smith, C.
Nankervis, H.
Burton, C.
Masterson-Algar, P.
Ives, N.
Jowett, S.
Abdali, Z.
Sharp, L.
Jeffreys, T.
Clarke, C.
MOVEMENT DISORDERS, 2022, 37 : S131 - S131
[4] Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial
Scobie, Sarah
Jowett, Sue
Lambe, Tosin
Patel, Smitaa
Woolley, Rebecca
Ives, Natalie
Rick, Caroline
Smith, Christina
Brady, Marion C.
Clarke, Carl
Sackley, Cath
PILOT AND FEASIBILITY STUDIES, 2021, 7 (01)
[5] Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial
Sarah Scobie
Sue Jowett
Tosin Lambe
Smitaa Patel
Rebecca Woolley
Natalie Ives
Caroline Rick
Christina Smith
Marion C Brady
Carl Clarke
Cath Sackley
Pilot and Feasibility Studies, 7
[6] Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial
Sackley, Catherine M.
Smith, Christina H.
Rick, Caroline
Brady, Marian C.
Ives, Natalie
Patel, Ramilla
Roberts, Helen
Dowling, Francis
Jowett, Sue
Wheatley, Keith
Patel, Smitaa
Kelly, Debbie
Sands, Gina
Clarke, Carl
TRIALS, 2014, 15
[7] Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease (PD COMM pilot): study protocol for a randomized controlled trial
Catherine M Sackley
Christina H Smith
Caroline Rick
Marian C Brady
Natalie Ives
Ramilla Patel
Helen Roberts
Francis Dowling
Sue Jowett
Keith Wheatley
Smitaa Patel
Debbie Kelly
Gina Sands
Carl Clarke
Trials, 15
[8] A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial
Sackley, C. M.
Rick, C.
Au, P.
Brady, M. C.
Beaton, G.
Burton, C.
Caulfield, M.
Dickson, S.
Dowling, F.
Hughes, M.
Ives, N.
Jowett, S.
Masterson-Algar, P.
Nicoll, A.
Patel, S.
Smith, C. H.
Woolley, R.
Clarke, C. E.
TRIALS, 2020, 21 (01)
[9] A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial
C. M. Sackley
C. Rick
P. Au
M. C. Brady
G. Beaton
C. Burton
M. Caulfield
S. Dickson
F. Dowling
M. Hughes
N. Ives
S. Jowett
P. Masterson-Algar
A. Nicoll
S. Patel
C. H. Smith
R. Woolley
C. E. Clarke
Trials, 21
[10] Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial
Sackley, Catherine M.
Rick, Caroline
Brady, Marian C.
Woolley, Rebecca
Burton, Christopher
Patel, Smitaa
Masterson-Algar, Patricia
Nicoll, Avril
Smith, Christina H.
Jowett, Sue
Ives, Natalie
Beaton, Gillian
Dickson, Sylvia
Ottridge, Ryan
Nankervis, Helen
Clarke, Carl E.
BMJ-BRITISH MEDICAL JOURNAL, 2024, 386

← 1 2 3 4 5 →